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RIG-I-mediated type I interferon (IFN) production and
nuclease-mediated viral RNA degradation are essen-
tial for antiviral innate immune responses. DDX60 is
an IFN-inducible cytoplasmic helicase. Here, we
report that DDX60 is a sentinel for both RIG-I activa-
tion and viral RNA degradation. We show that
DDX60 is an upstream factor of RIG-I that activates
RIG-I signaling in a ligand-specific manner. DDX60
knockout attenuates RIG-I signaling and significantly
reduces virus-induced type I IFN production in vivo.
In addition, we show that DDX60 is involved in RIG-
I-independent viral RNA degradation. DDX60 and
RIG-I adaptor MAVS double-knockout mice reveal
a role for DDX60-dependent RNA degradation in
antiviral responses. Several viruses induced DDX60
phosphorylation via epidermal growth factor recep-
tor (EGFR), leading to attenuation of the DDX60 anti-
viral activities. Our results define DDX60 as a sentinel
for cytoplasmic antiviral response, which is counter-
acted by virus-mediated EGF receptor activation.
INTRODUCTION
The innate immune system is essential for controlling viral
infection. Cytoplasmic viral RNA and polyI:C are recognized by
RIG-I-like receptors including RIG-I and MDA5, which trigger
the induction of type I and III interferons (IFNs) and other inflam-
matory cytokines via the MAVS adaptor molecule (also called
IPS-1, Cardif, and VISA) (Loo and Gale, 2011). MAVS activates
TBK1 protein kinase, leading to autophosphorylation of TBK1
(Soulat et al., 2008). Autophosphorylated TBK1 is essential for
IRF-3 phosphorylation, which results in type I IFN expression
(Soulat et al., 2008).CThe RIG-I protein comprises two N-terminal caspase-activa-
tion and recruitment domains (CARDs), a DExD/H box (DDX)
helicase domain, and a C-terminal regulatory domain (RD) (Saito
et al., 2007). The RD and DDX helicase domains bind double-
stranded RNA (dsRNA) (Takahasi et al., 2008), leading to K63-
linked polyubiquitination of the RD by the Riplet ubiquitin ligase
(Oshiumi et al., 2013). Riplet-mediated ubiquitination allows
TRIM25 to access RIG-I CARDs, which is essential for triggering
the induction of type I IFN production via the MAVS adaptor
(Chan and Gack, 2015; Oshiumi et al., 2013). In contrast, cyto-
plasmic viral DNA is recognized byDNA sensors, including cyclic
GMP-AMP synthase (cGAS), DAI, IFI16, DDX41, and Mre11
(Desmet and Ishii, 2012; Kondo et al., 2013). Chen and col-
leagues have recently shown that cGAS is essential for type I
IFN production in response to viral DNA (Gao et al., 2013; Li
et al., 2013a; Sun et al., 2013). Those cytoplasmic nucleic acids
sensors require sentinels for recognition of viral RNA and DNA.
The high mobility group box proteins, HMGB1, 2, and 3, bind
to cytoplasmic immunogenic nucleic acids and function as uni-
versal sentinels for RNA and DNA sensors (Yanai et al., 2009).
Approximately 60 genes encode DDX helicases in the human
genome. Bowie and colleagues first reported that a member of
the DDX superfamily is involved in RIG-I signaling (Schro¨der
et al., 2008; Soulat et al., 2008). Subsequently, other studies
have shown that DDX superfamily members such as DDX3,
DHX29, DHX36, and DDX60 are involved in RIG-I-dependent
type I IFN production in response to viral RNA and DNA (Desmet
and Ishii, 2012; Sugimoto et al., 2014; Yoo et al., 2014). However,
the in vivo roles of these non-RIG-I-like helicases remain unclear.
DDX60 (also called FLJ20035) is an IFN-inducible gene that
has been identified via a microarray analysis of genes induced
by viral infection in human dendritic cells (DCs) (Miyashita et al.,
2011). The ectopically expressed DDX60 protein associates
with RIG-I and promotes RIG-I RNA-binding activity, leading to
RIG-I-mediated type I IFN expression (Miyashita et al., 2011).
The DDX60 helicase domain binds to viral RNA and DNA, and
the DDX60 ATP-binding site is essential for DDX60-mediatedell Reports 11, 1193–1207, May 26, 2015 ª2015 The Authors 1193
A B C
D
E
F G H
I
(legend on next page)
1194 Cell Reports 11, 1193–1207, May 26, 2015 ª2015 The Authors
RIG-I activation (Miyashita et al., 2011).Genetic studies indicated
that DDX60 acts upstream of RIG-I in the innate immune
response (Miyashita et al., 2011). In contrast, Riceandcolleagues
have shown that ectopically expressed DDX60 suppresses
hepatitis C virus (HCV) replication in aRIG-I-independentmanner
(Schoggins et al., 2011); however, the underlying mechanism
remains unknown. A DDX60 paralog, DDX60L, is located up-
stream of DDX60, and the DDX60L protein shows similarity to
DDX60; however, the function of DDX60L remains unknown.
Cytoplasmic viral RNA degradation pathways are important
for the suppression of viral replication. The Xrn1 RNA 5030
exonuclease plays a crucial role in HCV RNA degradation and
suppresses HCV replication (Li et al., 2013b). The zinc-finger
antiviral protein (ZAP) is a host antiviral factor required for the
degradation of viral RNA (Chen et al., 2008; Guo et al., 2007).
ZAP associates with components of the RNA exosome, which
is a protein complex essential for processing the 30 end of host
and viral RNAs (Houseley et al., 2006). Several DDX helicases
are essential for RNA exosome function (Schmid and Jensen,
2008). A phylogenetic analysis indicated that the DDX60 RNA
helicase domain is similar to a component of the RNA exosome,
Ski2, and DDX60 associates with RNA exosome core compo-
nents (Miyashita et al., 2011); however, the role of DDX60 in
RNA degradation by RNA exosome remains unclear.
HCV, the influenza A virus, and other viruses are known to acti-
vate the epidermal growth factor (EGF) receptor, which is a Tyr
kinase receptor (Diao et al., 2012; Ueki et al., 2013). Influenza
A virus- and respiratory-virus-induced EGF receptor activation
suppresses IRF1-induced type III IFN production (Ueki et al.,
2013). The HCV-induced EGF receptor activation reduces
STAT3 phosphorylation and STAT1 dimerization and attenuates
IFN-induced antiviral activities (Lupberger et al., 2013). A previ-
ous proteome analysis has shown that DDX60 is phosphorylated
by the EGF receptor (Tong et al., 2008); however, the physiolog-
ical role of DDX60 phosphorylation remains unknown. In this
study, we demonstrated that DDX60 plays a crucial role in the
antiviral innate immune response in vivo and that the DDX60
antiviral activities are regulated by EGF signaling.
RESULTS
DDX60 Associates with the RIG-I RNA Sensor
First, we investigated the physical interaction between endoge-
nous DDX60 and RIG-I. Endogenous DDX60 protein levelsFigure 1. DDX60 Is a Sentinel Helicase for Cytoplasmic Viral RNA Sens
(A and B) HEK293FT cells were stimulated with short polyI:C transfection. Who
cipitation (IP) was performed with antibody to DDX60 or control immunoglobulin
anti-DDX60, and anti-b-actin antibodies.
(C and D) HeLa cells were infected with VSV for 9 hr or transfected with short poly
6 hr, then fixed and stained for RIG-I, DDX60, or G3BP and with DAPI.
(E and F) siRNAs for negative control, DDX3, DDX60, and DDX60Lwere transfecte
ssRNA, 63 bp of 50-triphosphated ssRNA (50-ppp ssRNA), or salmon sperm genom
(internal control) vectors for 24 hr, and luciferase activity was determined.
(G) siRNAs as indicated were transfected into HEK293 cells for 48 hr. RIG-I and
p125luc and Renilla luciferase vectors for 24 hr, and luciferase activity was dete
(H and I) siRNAs as indicted were transfected into HeLa cells for 48 hr. R-polyI:C w
stained with anti-RIG-I (H) or anti-HMGB1 (I) antibody. The localizations of R-po
The scale bar represents 10 mm. Data are presented as mean ± SD. See also Fig
Cincreased after transfection with a RIG-I ligand, short polyI:C
(Figure 1A), and endogenous RIG-I was co-immunoprecipitated
with endogenous DDX60 protein after short polyI:C transfection
(Figure 1B), suggesting a physical interaction between endoge-
nous RIG-I and DDX60. Second, we investigated subcellular
localization of DDX60. Endogenous DDX60 protein exhibited a
cytoplasmic localization in resting cells, and the DDX60 staining
became strong after vesicular stomatitis virus (VSV) infection or
transfection with short polyI:C (Figure 1C). Colocalization of
DDX60with RIG-I was detected after VSV infection or stimulation
with short polyI:C transfection (Figure 1C). RIG-I localizes at
stress granule after stimulation with short polyI:C transfection
(Onomoto et al., 2012). As observed for RIG-I, DDX60 colocal-
ized with transfected rhodamine-conjugated short polyI:C
(R-polyI:C) and the stress-granule marker G3BP after transfec-
tion with short poly I:C or another RIG-I ligand, HCV 30-UTR
dsRNA (Saito et al., 2008) (Figure 1D). Taken together, these
data indicate that DDX60 binds to RIG-I after stimulation.
To evaluate the role of DDX60 in RIG-I-mediated signaling,
we next investigated the effect of DDX60 knockdown on RIG-I
signaling. DDX60 knockdown reduced IFN-b promoter acti-
vation in response to short polyI:C or HCV 30 UTR dsRNA
transfection (Figure 1E). In contrast, DDX60 knockdown failed
to reduce this promoter activation in response to other RIG-I
ligands, in-vitro-transcribed HCV JFH1 single-stranded RNA
(ssRNA) (Saito et al., 2008) or a 63-nt 50 triphosphated ssRNA
(50-ppp ssRNA) (Takahasi et al., 2008) (Figure 1E). Unlike
DDX60, knockdown of other DDX superfamily members
(DDX60L or DDX30) reduced the promoter activation induced
by the four RIG-I ligands (Figures 1E and S1A). DDX3, but not
DDX60 or DDX60L, knockdown reduced the promoter activa-
tion in response to salmon genomic DNA transfection (Fig-
ure 1F). These data suggest a ligand-specific involvement of
DDX60 in RIG-I signaling.
DDX60, DDX60L, and DDX3 knockdown did not reduce the
promoter activation induced by RIG-I and Riplet ectopic expres-
sion (Figure 1G). A microscopic analysis showed that RIG-I
colocalized with transfected R-polyI:C, whereas colocalization
was barely detected in DDX60-, DDX60L-, and DDX3-knock-
down cells (Figures 1H and S1B). HMGB1 universal sentinel
localization on transfected R-polyI:C was detected even in
DDX60-, DDX60L-, and DDX3-knockdown cells (Figures 1I and
S1B). Taken together, these data suggest that DDX60 acts
upstream of RIG-I.or RIG-I
le-cell extract (WCE) was prepared at the indicated time points. Immunopre-
G (IgG). The samples were analyzed by immunoblot assay using anti-RIG-I,
I:C, rhodamine-conjugated short polyI:C (R-polyI:C), or HCV 30-UTR dsRNA for
d into HEK293 cells for 48–72 hr. Short polyI:C, HCV 30 UTR dsRNA, HCVJFH1
ic DNA was transfected into HEK293 cells with p125luc and Renilla luciferase
Riplet expression vectors were transfected into HEK293 cells together with
rmined.
as transfected into HeLa cells for 6 hr (H) or 16 hr (I), and the cells were fixed and
lyI:C and the endogenous proteins were observed with confocal microscopy.
ure S1.
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Generation of DDX60-Deficient Mice
Human DDX60 and DDX60L are located in tandem on chromo-
some IV (Figure 2A). DDX60L mRNA was expressed in lymph
node, prostate, stomach, thyroid, tongue, and trachea and was
induced by type I IFN stimulation in HeLa cells asDDX60 (Figures
S2A and S2B). The phylogenetic tree constructed with DDX60
and DDX60L protein sequences indicated that mouse DDX60
is an ortholog of human DDX60, but not DDX60L (Figure S2C).
To further clarify the role of DDX60 in the RIG-I-dependent
pathway, we generated a DDX60-deficient mouse. Exon 10
of mouse DDX60 was removed by a gene-targeting method
(Figure 2B). RNA expression of exon 10 was not detected in
the DDX60-homozygous mutants, and expression of exon
30–31 regions was lower than 5% of the expression level de-
tected in wild-type (WT) mice (Figure S2D). RIG-I, MDA5,
MAVS, TICAM-1, and TLR3 expression was not affected by the
DDX60 mutation (Figure S2E). DDX60-knockout (DDX60-KO)
mice were born at the expected Mendelian ratio and exhibited
normal development and breading (Figure S2F).
Mouse DDX60 Is Involved in the RIG-I-Dependent Type I
IFN Expression Pathway
WT and DDX60-KO mouse embryonic fibroblast (MEF) cells
were stimulated with HCV JFH1 ssRNA, HCV 30 UTR dsRNA,
or short polyI:C transfection, and the activation of the IFN-b
promoter was determined by reporter-gene assay. Unlike human
DDX60, mouse DDX60 was required for promoter activation in
response to all three RIG-I ligands (Figure 2C). We determined
the IFN-a, IFN-b, and interleukin-6 (IL-6) protein levels in culture
medium by ELISA. DDX60 KO reduced IFN-a, IFN-b, and IL-6
production from MEFs in response to the three RIG-I ligands
(Figures 2D–2F), whereas residual type I IFN and IL-6 production
was still detected in DDX60 KO MEFs (Figures 2D–2F). These
data indicate the existence of DDX60-dependent and DDX60-in-
dependent pathways during RIG-I activation. Unlike HEK293
cells, 50-ppp ssRNA did not induce IFN-b and IL-6 production
from MEFs (Figures 2D and 2F).
DDX60 KO reduced the endogenous IFN-b and IFN-a2 mRNA
expression induced by short polyI:C, HCV 30 UTR dsRNA, or
VSV infection (Figures 2G–2I). VSV-induced IFN-l2/3 mRNA
expression was also reduced by DDX60 KO (see below). TBK1
phosphorylation was induced by short polyI:C transfection, and
DDX60 KO reduced the phosphorylation of TBK1 (Figure 2J). In
contrast, IFN-b and IFN-a2 mRNA expression induced by lipo-
polysaccharide (LPS) stimulation were comparable between
WT and DDX60 KO MEFs (Figure 2K). DDX60 KO reducedFigure 2. DDX60 Plays a Crucial Role in Type I IFN Expression in MEFs
(A) Schematic representation of PALLD-ANXA10 loci of human, chimpanzee, Rh
(B) Schematic representation of DDX60 locus showing its exon (boxes) and intro
(C) Wild-type (WT) and DDX60 KOMEFs were transfected with 0.1 mg HCV JFH1 s
Renilla luciferase vectors, and luciferase activity was subsequently determined.
(DI) WT and DDX60 KO MEFs were transfected with indicated ligand or infecte
protein levels in culture medium were determined by ELISA. Type I IFN mRNA e
(J) WT and DDX60 KO MEFs were stimulated with short polyI:C transfection. W
SDS-PAGE and immunoblot analysis using anti-phospho-TBK1 (p-TBK1), TBK1
(KM)WT andDDX60 KOMEFs were stimulated with LPS (K) or salmon genomic
indicated time points, and IFN-a2 and IFN-b mRNA expressions were determine
Data are presented as mean ± SD. See also Figure S2.
CdsDNA- or HSV-1-induced IFN-a2 mRNA expression only at
early time points and failed to reduce IFN-b mRNA expression
(Figures 2L and 2M). Taken together, our data demonstrate that
DDX60 plays a crucial role for RIG-I activation in fibroblast cells.
Although DDX60 was ubiquitously expressed in mouse tis-
sues, its expression level was different among different tissues
(Figure 3A). Bone-marrow-derived dendritic cells (BM-DCs)
robustly expressed DDX3 and DHX36, which are involved in
the RIG-I activation pathway (Oshiumi et al., 2010b; Yoo et al.,
2014), whereas DDX60 was exclusively expressed in peritoneal
macrophages (Figure 3A).
Next,weexamined the roleofDDX60 inDCsandmacrophages.
Interestingly, DDX60 KO reduced virus- or RIG-I-ligand-induced
IFN-a and IFN-b production in peritoneal macrophages, but not
in BM-DCs (Figure 3B–3E). Next, we investigated the role of
DDX60 in splenic CD11c+ cells. KO of DDX60 also reduced type
I IFN production from splenic CD11c+ cells after VSV infection
(Figure S3). These data indicated that DDX60 is required for
RIG-I-mediated type I IFN production in peritoneal macrophages
and splenic CD11c+ cells, and our data also indicate a cell-type-
specific role of DDX60 in RIG-I activation.
DDX60 KO reduced HSV-1-induced IFN-a production in
peritoneal macrophages (Figure 3F), whereas DDX60 was
dispensable for HSV-1-induced IFN-b production in BM-DCs
or peritoneal macrophages (Figure 3F and 3G). These data
suggest that DDX60 plays only a minor role in the DNA-sensing
pathway.
DDX60 Plays a Crucial Role in Type I IFN Production
In Vivo
Next, we investigated the in vivo role of DDX60. First, we
observed type I IFN levels in sera after intraperitoneal injection
of short polyI:C. Serum IFN-b levels in DDX60-KO mice were
comparable to those of WT mice (Figure 4A).
Second, we observed hepatic type I IFN expression in
response to hydrodynamically injected HCV RNA as described
previously (Okamoto et al., 2014; Saito et al., 2008). RIG-I KO
abolishes hepatic type I IFN expression in response to hydro-
dynamically injected HCV JFH1 ssRNA (Saito et al., 2008).
Although HCV RNA levels in DDX60-KO mouse livers were
slightly higher than those detected in WT mouse livers (Fig-
ure 4B), DDX60 KO markedly reduced hepatic IFN-b and
IFN-a2 mRNA levels and serum IFN-b protein levels after hydro-
dynamic injection (Figures 4C and 4D).
Third, we investigated in vivo the antiviral innate immune
response after intraperitoneal VSV infection. DDX60 KO reducedesus macaque, cattle, mouse, and chicken.
ns (lines). Exon 10 was replaced with the gene cassette.
sRNA, HCV 30 UTR dsRNA, or short polyI:C for 24 hr together with p125luc and
d with VSV (MOI = 10). 24 hr after stimulation, type I IFN (D and E) and IL-6 (F)
xpression at indicated time point was determined by qRT-PCR (GI).
hole-cell lysate was prepared at the indicated time points and subjected to
(total TBK1), and b-actin antibodies.
DNA (dsDNA) transfection (L) or infected with HSV-1 (M). RNA was extracted at
d by qRT-PCR.
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Figure 4. DDX60 Plays a Crucial Role in Antiviral Innate Immune Responses In Vivo
(A) 50 mg poly I:C was intraperitoneally (i.p.) injected into WT and DDX60-deficient mice. Serum IFN-b levels were determined by ELISA (mean ± SD; n = 3).
(BD) In vitro synthesized HCV JHF-1 GND ssRNA was hydrodynamically injected into wild-type (WT) and DDX60 KO mice. 7 hr after hydrodynamic injection,
total RNA was extracted from mouse livers, and HCV RNA levels (B) and IFN-a2 and IFN-b mRNA expression levels (C) were determined by qRT-PCR and
normalized to b-actin levels. The IFN-a and IFN-b protein levels in sera 7 hr after hydrodynamic injection were determined by ELISA (D). Data are presented as
mean ± SD.
(E and F) 13 107 plaque-forming units (PFU) of VSV was i.p. injected into WT and DDX60-deficient mice. 14 hr after infection, IFN-a and IFN-b levels in sera were
determined by ELISA (E). Splenic IP-10, CCL5, and IFN-l2/3 mRNA expression was determined by qRT-PCR and normalized to b-actin (F).
(G) WT and DDX60 KOmice were intranasally infected with 23 106 PFU of VSV and sacrificed on day 4 after infection. Titers in mouse brain were determined by
the plaque assay.
See also Figure S4.serum IFN-a protein levels after VSV infection, and VSV-induced
splenic IP-10, CCL5, and IFN-l2/3 mRNA expression was also
reduced by DDX60 KO (Figures 4E and 4F). DDX60 KO signifi-
cantly increased viral titers in mouse brain after intranasal VSV
infection (Figure 4G). VSV RNA levels in mouse brain and lung
were also increased by DDX60 KO (Figure S4). These data indi-
cate that DDX60 plays a crucial role in the RIG-I-dependent
innate immune response in vivo.
EGF Attenuates RIG-I Signaling via DDX60
Phosphorylation
Next, we focused on regulatory mechanism of DDX60 function.
Several viruses activate the EGF receptor to facilitate viral infec-Figure 3. Cell-Type-Specific Role of DDX60 in Type I IFN Expression
(A) Total RNAwas extracted fromBM-DCs, peritoneal macrophages, andmouse t
and normalized to b-actin.
(BG) Wild-type (WT) and DDX60-KO peritoneal macrophages and BM-DCs were
0.1 mgHCV 30 UTR dsRNA (HCVRNA) for 16 hr (D and E), and then IFN-a and IFN-b
as means ± SD (n = 3).
See also Figure S3.
Ction (Ueki et al., 2013). A recent mass-spectrometry analysis
has shown that two tyrosine residues of DDX60 (Tyr-793 and
Tyr-796) are phosphorylated by the EGF receptor (Tong et al.,
2008). The two residues are located in the vicinity of the
Lys-791 residue, which is important for DDX60 ATP-binding
activity (Figure 5A); moreover, the K791A mutation is known to
reduce DDX60-dependent RIG-I activation (Miyashita et al.,
2011). Thus, we investigated whether EGF receptor activation
attenuates the antiviral innate immune response via DDX60
phosphorylation.
First, we examined whether the activation of the EGF receptor
induces DDX60 Tyr phosphorylation. For this purpose, we con-
structed a DDX60-YF mutant, in which Tyr-793 and Tyr-796issues as indicated. ThemRNA of each DDX genewas determined by qRT-PCR
infected with VSV (B), SeV (C), or HSV-1 (F and G) for 16 hr or transfected with
levels in culturemediumwere determined by ELISA. The results are expressed
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Figure 5. EGF-Induced DDX60 Phosphorylation Impairs DDX60 ATP-Binding Activity
(A and B) Schematic representation of the DDX60 ATP-binding site (A) and a DDX60-YF mutant (B).
(C and D) HEK293 cells were cultured in medium supplemented with or without 10 ng/ml EGF and transfected with a vector carrying HA-tagged DDX60 for 24 hr.
Lysates were immunoprecipitated with anti-phospho-tyrosine (p-Y) antibody. The proteins were detected with anti-HA and b-actin antibodies (C). The band
intensities were normalized to b-actin intensity (D).
(E and F) HEK293 cells were cultured in medium supplemented with 10 ng/ml EGF and transfected with a vector carrying HA-tagged DDX60 or DDX60-YF for
24 hr. Lysates were immunoprecipitated with anti-p-Y antibody. The proteins were detected with anti-HA and b-actin antibodies (E). The band intensities were
normalized to b-actin intensity (F).
(legend continued on next page)
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were replaced with Phe residues (Figure 5B). HEK293 cells ex-
pressing hemagglutinin (HA)-tagged DDX60 were cultured in
medium supplemented with or without 10 ng/ml EGF for 24 hr.
A cell lysate was prepared, and phospho-Tyr (p-Y) proteins
were subsequently immunoprecipitated using an anti-p-Y anti-
body. The precipitated phospho-DDX60 (p-DDX60) proteins
were detected by western blotting. We found that p-DDX60
was significantly increased by EGF treatment (Figure 5C and
5D) and that the DDX60-YF mutation reduced EGF-induced
DDX60 Tyr-phosphorylation (Figures 5E and 5F). This indicated
that the phosphorylation of DDX60 Tyr-793 and Tyr-796 was
induced by EGF treatment.
Second, we investigated the effect of Tyr phosphorylation on
DDX60 function. To test the ATP-binding activity, we performed
a pull-down assay with ATP-analog-conjugated agarose beads.
Interestingly, EGF treatment reduced DDX60-ATP binding activ-
ity (Figures 5G and 5H). Next, we investigated the RNA-binding
activity of DDX60 by a pull-down assay with biotin-conjugated
dsRNA. EGF treatment did not reduce DDX60 RNA-binding
activity (Figures 5I and 5J). Microscopic observation showed
that ectopically expressed DDX60 was partially colocalized
with the EGF receptor before and after EGF treatment, and
DDX60 aggregates appeared after EGF treatment (Figures 5K
and S5).
Third, we investigated whether endogenous DDX60 Tyr phos-
phorylation is induced by the EGF treatment. To test this possi-
bility, we used a proximity ligation assay (PLA), which enables
the visualization of endogenous protein modification (Jarvius
et al., 2007). We used anti-DDX60 and anti-p-Y antibodies. If
endogenous DDX60 Tyr residues are phosphorylated after EGF
treatment, it is expected that the PLA-positive (p-Y-DDX60)
signals will increase. As expected, the p-Y-DDX60 signals
were increased by EGF treatment in HeLa and HuH-7 cells (Fig-
ures 6A–6D).
Fourth, we investigated the effect of EGF on endogenous
DDX60 function. If EGF treatment impairs DDX60-dependent
RIG-I activation, it will reduce RIG-I signaling. As expected,
EGF treatment reduced IFN-b and IFN-l1 promoter activation
induced by short polyI:C transfection in HEK293, HuH-7, and
MEF cells (Figures 6E and 6F). Long polyI:C-mediated IFN-b pro-
moter activation was moderately reduced by EGF treatment
(Figure 6G). Conversely, knockdown of the EGF receptor
enhanced short polyI:C-induced IFN-b promoter activation (Fig-
ure 6H). VSV-induced IRF3 phosphorylation and IFN-b expres-
sion was also enhanced by EGF receptor knockdown (Figures
6I and 6J). In contrast, MAVS-induced IFN-b promoter activation
was not reduced by EGF treatment (Figure 6K). Overexpression
of DDX60-YF, which is resistant to EGF, canceled the EGF effect(G and H) HEK293 cells were cultured in medium supplemented with or without 1
transfection, cell lysates were prepared, and then a pull-down assay was performe
with anti-HA and b-actin antibodies (G). The band intensities were normalized to
(I and J) HEK293 cells were cultured in medium supplemented with or without
expression vectors were transfected. 24 hr after transfection, a pull-down assay w
immunoblotting with anti-HA and FLAG antibodies (I). The band intensities were
(K) HuH-7 cells were transfected with DDX60-HA or FLAG-RIG-I expressing vec
indicated time points and stained with anti-EGFR and anti-HA or -FLAG antibod
See also Figure S5.
Con IFN-b promoter activation (Figure 6L), suggesting that EGF
treatment reduces IFN-b promoter activation via DDX60. More-
over, EGF treatment reduced polyI:C-induced IFN-b promoter
activation in WT MEFs, but not in DDX60-KO MEFs (Figure 6M).
Taken together, these data indicate that EGF treatment attenu-
ates RIG-I-mediated IFN-b promoter activation via DDX60
phosphorylation.
Viruses Modulate DDX60 Function via EGF Signaling
Influenza A virus and HCV activate the EGF receptor, and inhib-
itors of the EGF receptor augment innate immune responses
during viral infections (Lupberger et al., 2013; Ueki et al., 2013).
We performed a PLA and found that influenza A virus infec-
tion increased p-Y-DDX60 signals and HCV infection induced
p-Y-DDX60 signals (Figures 6N, 6O, and S6A), suggesting
that influenza A virus and HCV induce endogenous DDX60
phosphorylation. We found that colocalization of endogenous
DDX60 and EGF receptor increased after influenza A virus
infection (Figures 6P and 6Q). EGF treatment reduced VSV- or
influenza A virus-induced IFN-b, IP10, and tumor necrosis factor
a (TNF-a) mRNA expression in HeLa cells, whichwere cultured in
serum-freemedium (Figures S6B andS6C), and an EGF receptor
inhibitor, erlotinib, increased influenza A virus-induced IFN-b and
IP10 mRNA expression (Figure S6D). To investigate the role of
DDX60 in the EGF-mediated suppression during viral infection,
WT andDDX60KOMEFswere infectedwith VSV in the presence
or absence of EGF. Although DDX60 KO reduced VSV-induced
IFN-b and IFN-l2/3 expression in MEFs cultured in serum-free
medium, DDX60 KO failed to reduce IFN expression in cells
cultured in serum-free medium supplemented with 10 ng/ml
EGF (Figure 6R). Taken together, these data indicate that
virus induces DDX60 phosphorylation via EGF receptor activa-
tion, which results in attenuation of DDX60-dependent RIG-I
activation.
DDX60 Is Involved in a Viral RNA Degradation Pathway
Previously, Rice and colleagues have reported that ectopically
expressed DDX60 suppresses HCV replication in a RIG-I-inde-
pendent manner (Schoggins et al., 2011). Although Riplet and
MAVS were inactivated in a hepatocyte cell line (O cells) that
contained HCV 1b full-length replicons (Oshiumi et al., 2013),
DDX60 knockdown increased HCV RNA levels in O cells (Fig-
ure 7A), suggesting the existence of RIG-I-independent DDX60
antiviral activity. Thus, we next investigated the RIG-I-indepen-
dent antiviral activity. DDX60 is similar to SKI2, a component of
the RNA exosome, which degrades host and viral RNAs. Small
interfering RNA (siRNA) for EXOSC4, a core component of
the RNA exosome, also increased HCV RNA levels in O cells0 ng/ml EGF for 24 hr, and then HA-tagged DDX60 was transfected. 24 hr after
d with ATP analog-agarose. Bound proteins were analyzed by immunoblotting
b-actin intensity (H).
10 ng/ml EGF for 24 hr, and HA-tagged DDX60 and/or FLAG-tagged RIG-I
as performed with biotin-conjugated dsRNA. Bound proteins were analyzed by
normalized to b-actin intensity (J).
tor for 24 hr, then stimulated with mock or 100 ng/ml EGF. Cells were fixed at
ies. The scale bar represents 10 mm.
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(Figure 7B). To test the role of DDX60 in viral RNA degradation,
we carried out electroporation assay as described before (Li
et al., 2013b). A replication defective HCV JFH1-GND ssRNA
was electroporated into HuH-7.5 cells, and viral RNA levels
were subsequently determined by qRT-PCR. As expected,
DDX60 knockdown delayed HCV RNA degradation in HuH-7.5
cells or RIG-I knockdown HuH-7 cells (Figures 7C and 7D).
Next, we used an inhibitor for HCV polymerase, MK-0608, and
investigated viral RNA decay as described previously (Sedano
and Sarnow, 2014). siRNA for DDX60 delayed the HCV RNA
decay after addition of the inhibitor (Figure 6E). As seen with
DDX60 knockdown, EXOSC4 knockdown also delayed the
degradation of electroporated HCV RNA in HuH-7.5 cells (Fig-
ure 7F), and co-localization of endogenous DDX60 with EXOSC4
was detected in O cells (Figure 7G). These data indicate that
DDX60 is involved in HCV RNA degradation. To further corrobo-
rate the RIG-I-independent DDX60 function, we investigated the
DDX60 antiviral activity in RIG-I-deficient HuH7.5 cells (Saito
et al., 2007). We found that siRNA for DDX60 augmented cyto-
pathic effect of VSV on HuH-7.5 cells and increased VSV titer
in culture medium (Figure 7H), and siRNA for DDX60 delayed
VSV dsRNA degradation (Figure 7I). The degradation of VSV
dsRNA or HCV JFH1 GND ssRNA was also delayed in DDX60
KO MEFs (Figures 7J and 7K). Collectively, our data indicate
that DDX60 is involved in a RIG-I-independent viral RNA degra-
dation pathway. We also observed that erlotinib treatment
increased HCV RNA degradation and reduced HCV RNA levels
in O cells (Figures 7L and 7M), indicating that EGF receptor acti-
vation attenuates not only DDX60-dependent RIG-I signaling but
also DDX60-dependent viral RNA degradation.
To investigate the role of DDX60 in antiviral response in vivo,
WT and DDX60-KO mice were intranasally infected with VSV,
and survival was monitored. DDX60 KO increased mortality afterFigure 6. EGF Induces Endogenous DDX60 Phosphorylation and Supp
(AD) HeLa cells cultured in serum-free medium (A and B) and HuH-7 cells in 10%
16 hr, then fixed and stained with anti-DDX60 and anti-p-Y antibodies. Co-loca
number of co-localization signals (PLA signals: p-Y-DDX60) per cell was counted
(E) HEK293, HuH-7, and immortalized MEF cells were cultured in medium supp
reporter (p125 luc) and Renilla luciferase together with or without short polyI:C. 24
as means ± SD (n = 3).
(F andG) HEK293 cells cultured inmedium supplementedwith 0 or 10 ng/ml EGFw
with Renilla luciferase vector. 24 hr after transfection, cells were stimulated with sh
(HJ) HEK293 cells cultured with or without 500 pg/ml EGFwere transfected with
short polyI:C was determined as in (G), and IRF3 phosphorylation induced by VSV
anti-IRF3, and anti-b-actin antibodies (I). VSV-induced IFN-b mRNA expression
(K) HEK293 cells cultured in medium supplemented with 0 or 10 ng/ml EGF we
together with Renilla luciferase vector. 24 hr after transfection, luciferase activity
(L) HEK293 cells cultured in medium supplemented with 0 or 10 ng/ml EGF were
vector, plus IFN-b reporter and Renilla luciferase plasmids. 24 hr after transfection
activity was determined.
(M) WT and DDX60-KO immortalized MEFs were cultured in medium supplement
determined as in (G).
(N and O) HeLa cells cultured in serum-free mediumwere infected with flu for 16 h
of p-Y and DDX60 (p-Y-DDX60) was detected by PLA (N). The number of coloca
mean ± SD (n > 10).
(P and Q) HeLa cell were mock-infected or infected with influenza A virus at MO
receptor (EGFR) was detected by PLA using anti-DDX60 and anti-EGFR antibod
(R)WT andDDX60KOMEFswere cultured in serum-freemedium supplementedw
was extracted at the indicated time points, and IFN-b and IFN-l2/3 mRNA expre
The scale bar represents 10 mm. See also Figure S6.
Cviral infection (Figure 7N). Next, we assessed the in vivo role of
RIG-I-independent DDX60 antiviral activity. We compared the
survival of MAVS and DDX60 double-KO mice with MAVS sin-
gle-KO mice after VSV infection. Interestingly, the double-KO
mice were more susceptible to VSV than MAVS single-KO
mice (Figure 7O), suggesting that RIG-I-independent DDX60
antiviral activity plays a crucial role in in vivo antiviral response.
DISCUSSION
DDX60 is an IFN-inducible gene, and the ectopically expressed
DDX60 protein associates with RIG-I (Miyashita et al., 2011).
Here, we demonstrated that DDX60 co-localized with the RIG-I
protein, RIG-I ligand, and a stress granule marker, G3BP, where
RIG-I recognizes viral RNA (Onomoto et al., 2012). We also
showed that DDX60 bound to RIG-I after stimulation. Consid-
ering that DDX60 acts upstream of RIG-I, our data support a
model inwhichDDX60 functions as a sentinel for RIG-I activation.
Cytoplasmic HMGBs bind to all immunogenic nucleic acids and
function as universal sentinels for RIG-I activation (Yanai et al.,
2009). In contrast, our data indicate the ligand-specific involve-
ment of DDX60 in RIG-I activation. These observations suggest
that RIG-I requires not only universal sentinels but also ligand-
specific sentinels for its activation. It is notable that other DDX
helicases, such as DDX3 and DDX60L, exhibited different spec-
ificities to nucleic acids. Helicase-related Snf2 family enzymes
are known to translocate DNA-associated proteins to regulate
nucleic acid metabolism, such as transcription or homologous
recombination (Kingston and Narlikar, 1999; Solinger et al.,
2002). Considering that DDX3 and DDX60 increase RIG-I binding
to dsRNA (Miyashita et al., 2011; Oshiumi et al., 2010b), these
DDX helicases might be required to translocate RNA-associated
proteins to promote RIG-I recognition of viral RNA.resses Type I IFN Expression
serum medium (C and D) were stimulated with or without 100 ng/ml EGF for
lization of DDX60 and p-Y (p-Y-DDX60) was detected by PLA (A and C). The
(means ± SD; n > 10) (B and D).
lemented with 0, 0.5, 1, or 10 ng/ml EGF and then transfected with an IFN-b
hr after transfection, luciferase activity was determined. The results expressed
ere transfectedwith IFN-l1 (F) or IFN-b reporter (p125 luc) (G) plasmid together
ort or long polyI:C transfection for 8 hr, and luciferase activity was determined.
siRNA for negative control or EGF receptor. The luciferase activities induced by
infection at MOI = 5 for 6 hr was detected by western blotting with anti-p-IRF3,
was determined by qRT-PCR (J).
re transfected with IFN-b reporter (p125 luc) and MAVS expressing plasmid
was determined.
transfected with vector expressing WT DDX60 or DDX60-YF mutant or empty
, cells were stimulated with short polyI:C for 8 hr by transfection, and luciferase
ed with or without 10 ng/ml EGF. Short polyI:C-induced luciferase activity was
r, then fixed and labeled with anti-DDX60 and anti-p-Y antibody. Colocalization
lization signals (PLA signals) per cell was counted (O). Data are presented as
I = 10 and fixed at indicated time points. Co-localization of DDX60 and EGF
ies (P). The ratio of the PLA-positive cells is shown (Q).
ith 0 or 10 ng/ml EGF for 24 hr and then infectedwith VSV atMOI = 1. Total RNA
ssion was determined by qRT-PCR.
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Figure 7. DDX60 Promotes Viral RNA Degradation
(A and B) siRNA for negative control,DDX60 (A), or EXOSC4 (B) was transfected into O cells with HCV replicons for 48 hr (A) or 72 hr (B), then HCV RNA levels were
determined by qRT-PCR. The results are expressed as mean ± SD (n = 3).
(legend continued on next page)
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MEFs, peritoneal macrophages, and splenic CD11c+ cells
required DDX60 for efficient type I IFN production, whereas
BM-DCs did not. These data indicate a cell-type-specific role
of DDX60. Because other DDX helicases are also involved in
RIG-I-mediated type I IFN production and highly expressed in
BM-DCs, those helicases might function as sentinels for RIG-I
and compensate for the defect of DDX60. Interestingly, Liu and
colleagues reported a cell-type-specific role of DHX29 (Sugi-
moto et al., 2014). These data indicate that there are several
cell-type-specific sentinel helicases for RIG-I activation.
Rice and colleagues showed that DDX60 antiviral activity is
specific for HCV and does not require RIG-I (Schoggins et al.,
2011). They used STAT-1-deficient cells, in which type I IFN
induced by RIG-I signaling cannot activate the antiviral response
(Schoggins et al., 2011). Here, we demonstrated that DDX60was
involved not only in RIG-I-mediated type I IFN signaling but also
in the RIG-I-independent HCV RNA degradation pathway. This
finding is consistent with the results of the previous study by
Rice and colleagues (Schoggins et al., 2011). DDX60 was
involved in VSV RNA degradation, and DDX60 and MAVS dou-
ble-KO mice were more susceptible to VSV infection than
MAVS single-KO mice. These data indicate that DDX60-medi-
ated viral RNA degradation plays a crucial role in antiviral
response in vivo.
Here, we revealed a regulatory mechanism of EGF-receptor-
mediated suppression of DDX60 antiviral activity. EGF signaling
induced DDX60 Tyr phosphorylation, resulting in malfunction of
its ATP binding activity required for antiviral activity. We also
found that EGF treatment induced DDX60 aggregation in the
cytoplasm. The aggregates might sequestrate or inhibit virus-
induced DDX60 and/or RIG-I at a later phase. Further study is
required to clarify the physiological significance of the cyto-
plasmic DDX60 aggregates induced by EGF signaling.
A recent study revealed that EGF signaling inhibited IRF1-
mediated type III IFN production (Ueki et al., 2013). Considering
that RIG-I activates IRF1 to induce type III IFN (Odendall et al.,
2014), EGF-signaling-mediated suppression of IRF1 might be
caused by DDX60 phosphorylation. On the other hand, it has
been reported that EGF signaling reduced STAT1 dimerization
(Lupberger et al., 2013). These observations imply that EGF re-
ceptor activation inhibits several steps of antiviral innate immune
responses. A previous study demonstrates that inhibitors for(C and D) HuH-7.5 (C) or HuH-7 (D) cells were transfected with siRNA for negative
GND RNA was electroporated into the cells. HCV RNA levels were determined b
(E) siRNA for negative control or DDX60 were transfected into HuH-7.5 cells prio
35 mM) was added to cells, after which HCV RNA levels at the indicated time po
(F) HuH-7.5 cells were transfected with negative control or EXOSC4 siRNA (C) for
the cells. HCV and EXOSC4 RNA levels were determined by qRT-PCR.
(G) FLAG-tagged EXOSC4 was transiently expressed in O cells. Cells were fixed
(H) HuH-7.5 cells were pre-treated with 200 IU of IFN-a for 24 hr and subsequen
crystal violet (upper panel). VSV titer in culture medium of the IFN-a treated cells
(IK) VSV dsRNA (I, J) or HCV JFH1-GND ssRNA (K) were electroporated into
(J and K). Viral RNA levels at the indicated time points were determined by qRT-
(L) HuH-7 cells cultured with or without 1 mM erlotinib for 48 hr were electroporate
(M) O cells with HCV replicons were treated with 1 mM of erlotinib for 6 days. The
levels were determined by qRT-PCR.
(N and O) Wild-type (WT), DDX60 single-KO, MAVS single-KO, and DDX60/MAV
2 3 105 PFU of VSV (O), and mice mortality was observed.
CEGF receptor suppress HCV infection in a human liver chimeric
mouse model in vivo (Lupberger et al., 2011). Therefore, virus-
mediated EGF receptor activation is important for virus to
escape the host innate immune response in vivo. Because
various types of viruses activate EGF receptor to facilitate their
replication (Ueki et al., 2013), our findings provide an insight
into the mechanism underlying the promotion of viral infection
and replication by virus-mediated EGF receptor activation.
Unlike what was observed for DDX60, EGF-receptor-medi-
ated Tyr phosphorylation is essential for the activation of TLR3,
which recognizes viral RNA (Yamashita et al., 2012). Thus, a
high EGF concentration is expected to promote the TLR3-medi-
ated, but not the DDX60-mediated, innate immune response.
TLR3 promotes cross-priming and activates cytotoxic T lympho-
cytes (Schulz et al., 2005). Conversely, the RIG-I pathway is
required for initial antiviral responses (Koyama et al., 2007).
Serum EGF and EGF receptor expression levels on the cell
surface are reduced during aging (Shurin et al., 2007). Thus,
EGF-mediated control of the innate immune responses may
be a cause of age-dependent functional changes in innate
immunity.
EXPERIMENTAL PROCEDURES
Cells, Viruses, and Reagents
Cell culture media for HEK293, HeLa, O, HuH-7, and HuH-7.5 cells were
described previously (Oshiumi et al., 2009, 2013). Preparation of mouse BM-
DCs and peritoneal macrophages was described previously (Oshiumi et al.,
2010a). WT and DDX60/ MEFs were prepared from day 12.5 to day 14.5
embryos. MEFs were immortalized using large T antigen of SV40. Preparation
of VSV Indiana strain, SeV (HVJ strain), and HSV-1 was described previously
(Miyashita et al., 2011). Influenza A virus (PR8) was provided by Y. Sakoda
(Hokkaido University). We used salmon sperm dsDNA (Invitrogen), erlotinib
(Funakoshi), mouse recombinant EGF, (Wako), anti-DDX60 polyclonal anti-
body (SIGMA), anti-HA polyclonal antibody (SIGMA), anti-b-actin monoclonal
antibody (AC-15) (SIGMA), anti-RIG-I monoclonal antibody (Alme-1) (Axxora
Platform), anti-G3BP antibody (Abcam), anti-NAK (TBK1) antibody (EP611Y)
(Abcam), anti-p-TBK1 rabbit monoclonal antibody (CST), anti-p-IRF3 (S396)
rabbit monoclonal antibody (CST), and anti-IRF3 antibody (Invitrogen and
Zymed). Preparation of viral RNA is described in Supplemental Experimental
Procedures.
Electroporation
1 mg viral RNA (HCV JFH-1 GND ssRNA or VSV dsRNA) and 13 106 cells were
suspended in 400 ml of OPTI-MEM I in a 4-mm cuvette and pulsed once atcontrol,DDX60, and/orRIG-I for 48 hr, and then in vitro synthesized HCV JFH-1
y RT-qPCR.
r to HCV JFH1 infection. 3 days after infection, MK-0608 (final concentration,
ints were determined by qRT-PCR.
48 hr, then in vitro synthesized HCV JFH-1 GND RNA was electroporated into
and stained with anti-DDX60 and anti-FLAG antibodies.
tly infected with VSV at MOI = 0.01 for 24 hr. Cells were fixed and stained with
was determined by plaque assay (lower panel).
control or DDX60-knockdown HuH-7.5 cells (I) or WT and DDX60-KO MEFs
PCR.
d with HCV JFH-1-GND RNA. HCV RNA levels were determined by qRT-PCR.
cell culture medium containing erlotinib was replaced every 2 days. HCV RNA
S double-KO mice were intranasally infected with 2 3 106 PFU of VSV (N) or
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250 V, 950 mF for HuH-7 and HuH-7.5 or at 400 V, 250 mF for MEFs in a Gene
Pulser II System (Bio-Rad).
Pull-Down Assay
An ATP affinity test kit was purchased from JENA BIOSCIENCE. 6AH-ATP-
agarose, 8AH-ATP-agarose, AP-ATP-agarose, and EDA-ATP-agarose were
mixed. An ATP affinity test was conducted according to the manufacturer’s
instructions. A pull-down assay using biotin-conjugated dsRNAwas described
previously (Oshiumi et al., 2013).
Treatment with EGF
To examine the effect of EGF on short polyI:C-induced IFN-b promoter activa-
tion, EGF was added to medium for HEK293 and HuH-7 cells 24 hr before
transfection. Cells were transfected with p125luc reporter, Renilla luciferase
vector (internal control), and short polyI:C for 24 hr. To investigate the effect
of DDX60-YFmutation, EGF was added to media of HEK293 cells 24 hr before
transfection. Cells were transfected with p125luc reporter, Renilla luciferase
vector, andWTDDX60 or DDX60-YF encoding vector for 24 hr and transfected
with short polyI:C for 8 hr. To investigate the effect of EGF on IFN-b, IP10, and
TNF-amRNA expression after VSV or Flu infection, HeLa cells were cultured in
serum-free media with or without EGF for 24 hr, and infected with VSV.
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